This article discusses the role of PET/CT in contributing to precision medicine in lung cancer,
and provides the perspective of the Society of Nuclear Medicine and Molecular Imaging …

Fluoro-deoxyglucose positron emission tomography (PET) imaging has a diagnostic and
prognostic value in the initial staging, restaging, and surveillance of non–small-cell lung …

More than one decade ago, introduction of integrated PET/CT scanners changed oncologic
imaging and oncologic patient management profoundly. With these systems, the metabolic …

This concise, excellently illustrated pocket book provides an up-to-date summary of the
science and practice of PET/CT imaging in lung cancer. The coverage encompasses the …

PET-CT is an exciting new imaging technology that simultaneously acquires detailed
structural and functional imaging information. PET is having an increasing inpact on the …

Since its introduction in 1974, positron emission tomography (PET) has gained widespread
use, especially in diagnosis and staging of lung cancer. In this respect, 18F …

Considering the potential of PET imaging for precision medicine and drug development in
lung and other types of cancer, increasing efforts are warranted to standardize PET …

Integrated functional and anatomical imaging using positron emission tomography (PET)/CT
hybrid scanners has changed the diagnostic algorithm in non-small cell lung cancer …

The use of PET/CT imaging in the work-up and management of patients with lung cancer
has greatly increased in recent decades. The ability to combine functional and anatomical …

In the last decade, FDG-PET scans have had a major impact on the treatment of patients
with NSCLC. The benefits of staging PET scans are well established, with improved …